Events - Spark Newswire

2 minute read

Jack Dorsey’s Block Co-Leads $2M Investment In Africa-Based Renewable Bitcoin Miner

Today, 3:58 PM

Gridless said that it has secured a $2 million seed investment round, led by Stillmark, a Bitcoin (CRYPTO: BTC)-focused venture capital firm and Twitter co-founder Jack Dorse

BTC

3 minute read

INmune Bio Reports Combination Therapy With INB03™ Overcomes Resistance To Trastuzumab-Deruxtecan In MUC4 Expressing HER2+ Breast Cancer

By Benzinga Newsdesk

Today, 3:58 PM

Neutralizing soluble TNF with INB03™ overcomes resistance to trastuzumab-deruxtecan in MUC4 expressing HER2+breast cancer. Combination therapy of INB03™ and trastuzumab-deruxtecan presented at the 45th

INMB

1 minute read

Events
News

Netflix Presenting Now At The UBS Global TMT Conference

By Benzinga Newsdesk

Today, 3:58 PM

https://event.webcasts.com/starthere.jsp?ei=1584608&tp_key=ada660851c

NFLX

2 minute read

Events
News

Fortune Brands Outlines Go-Forward Strategies For Two World-Class Publicly Traded Companies At 2022 Investor Day

By Benzinga Newsdesk

Today, 3:58 PM

Fortune Brands Home & Security, Inc. (NYSE:FBHS), an industry-leading home and security products company, today will host an Investor Day in advance of its planned separation into two world-class companies, which is

FBHS

1 minute read

Events
News

Southwest Airlines Co. 2022 Investor Day Dec. 7 At 12:00 p.m. ET

By Bill Haddad

Today, 3:58 PM

Date: Wednesday, December 7, 2022 Time: 12:00 p.m. ET Speakers: Bob

LUV

3 minute read

EXCLUSIVE: Matt Higgins About Passing On CryptoPunks; Lessons From Crypto, NFTs; And The Exciting Potential Of Blockchain Technology

By Chris Katje

Today, 3:58 PM

Entrepreneur and RSE Ventures CEO Matt Higgins has been in the cryptocurrency and NFT spaces for years and seen it all. Higgins shared with Benzinga his lessons learned and what could be next for Web3 in general.

$IMX

3 minute read

Quanterix’s Simoa Technology Drives Advances In Alzheimer’s Disease Research Presented At 2022 Clinical Trials On Alzheimer’s Disease Conference

By Michael Horton

Today, 3:58 PM

Quanterix Corporation (NASDAQ:QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that its Simoa® technology has powered important advances in ongoing

QTRX

3 minute read

Who Are The Winners And Losers Of G7 Price Cap On Russian Oil?

By Robert Kuczmarski

Today, 3:58 PM

Ahead of the OPEC + meeting this Sunday to discuss its oil production policy, the European Union decided to ban all maritime transports of imported Russian oil on Monday.

CVX

1 minute read

AIM ImmunoTech Announces Abstract Accepted For Poster Presentation At British Society For Immunology Congress 2022 Dec. 7

By Benzinga Newsdesk

Today, 3:58 PM

Poster No: P-220 Title: Safety, tolerability and biological activity of repeated intranasal administration of TLR3 agonist Ampligen (Poly I:Poly C12U) in healthy subjects Presenter: Lisanne C.A. Smidt -

AIM

5 minute read

Reported Late Thursday, ANAVEX2–73 Phase 2B/3 Study Met Primary And Key Secondary Endpoints, Showing Statistically Significant Reduction Of Clinical Decline In Global Clinical Study Of Patients With Early Alzheimer’s Disease; Shares Currently Halted

By Benzinga Newsdesk

Today, 3:58 PM

Robust, Statistically Significant and Clinically Meaningful Absolute Improvement in Cognitive Function as Measured by ADAS-Cog and ADCS-ADL Key Secondary Endpoint CDR-SB Also Met, Demonstrating Statistically

AVXL